Keyphrases
Glioblastoma Cells
100%
Cell Killing
100%
RNA Therapeutics
100%
Exosomes
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Cell Release
100%
Killing Activity
100%
MicroRNA-34a (miR-34a)
75%
Interleukin-13 (IL-13)
50%
MicroRNA
50%
Chimeric Antigen Receptor T-cell Therapy
50%
Co-expression
25%
Cell Apoptosis
25%
Solid Tumors
25%
Proliferation Apoptosis
25%
Binding Affinity
25%
Cancer Cell Proliferation
25%
U87 Cells
25%
Receptor Activation
25%
Solid Tumor Therapy
25%
Exportation
25%
Transgenic
25%
Cancer Metastasis
25%
In Situ Production
25%
Cell Therapy
25%
Non-hepatic
25%
Controlled Delivery
25%
Enhanced Toxicity
25%
MiR-181a-5p
25%
In Situ Delivery
25%
Chimeric Antigen Receptor Cells
25%
Receptor Molecules
25%
Minimal Promoter
25%
Cancer Antigen
25%
Co-stimulatory Domain
25%
Hepatic Tissue
25%
Concept Cells
25%
Pre-miR
25%
Immunology and Microbiology
Exosome
100%
Chimeric Antigen Receptor
100%
Cell Killing
100%
Chimeric Antigen Receptor T-Cell Therapy
50%
Cancer Cell
25%
Upregulation
25%
Promoter Region
25%
Cell Proliferation
25%
Chimeric Antigen Receptor T-Cell
25%
Binding Affinity
25%
Interleukin 13
25%
Transgenics
25%
Tumor Antigen
25%
Cytokine
25%
NFAT
25%
Programmed Cell Death
25%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
microRNA
100%
Chimeric Antigen Receptor
100%
microRNA 34a
42%
Solid Malignant Neoplasm
28%
Malignant Neoplasm
14%
Cytokine
14%
Interleukin 13
14%
Tumor Antigen
14%